The ESMO Award for Translational Research is presented to candidates who are internationally recognised for outstanding achievements in translational research.
2022 – Samra Turajlic, UK
The 2022 ESMO Translational Research Award was presented to Samra Turajlic from the Royal Marsden NHS Foundation Trust and the Francis Crick Institute, London, UK.
Turajlic has performed excellent work on cancer evolution, especially in kidney cancer, and she has been one of the driving forces behind COVID-19 vaccination in cancer patients research coming from the UK.
Previous recipients of the award (ESMO Award for Translational Research as of 2017, previously Hamilton Fairley Award)
- George Coukos, Switzerland (2021)
- Antoni Ribas, USA (2020)
- Charles Swanton, United Kingdom (2019)
- Pasi A. Jänne, USA (2018)
- Alberto Bardelli, Italy (2017)
- Carlos Caldas, United Kingdom (2016)
- Cornelis Punt, The Netherlands (2015)
- Heikki Joensuu, Finland (2014)
- Roger Stupp, Switzerland (2013)
- Jean-Yves Blay, France (2012)
- Rafael Rosell, Spain (2011)
- Bengt Glimelius, Sweden (2010)
- T. Andrew Lister, United Kingdom (2009)
- Yosef Yarden, Israel (2008)
- Volker Diehl, Germany (2006)
- Bruce Ponder, United Kingdom (2004)
- Alexander Levitzki, Israel (2002)
- Piet Borst, The Netherlands (2000)
- Thomas Tursz, France (1998)
- Albert de la Chapelle, Finland (1996)
- Bertrand Coiffier, France (1994)
- Herbert Michael Pinedo, The Netherlands (1992)
- Roland Mertelsmann, Germany (1990)
- Georg Klein, Sweden (1988)
Nomination and selection process
Nominations may be made by any ESMO member (except undergraduate medical or science student members). Candidates may not nominate themselves.
Candidate eligibility criteria
- Be an individual (institutions and organisations are not eligible) who has made an impact in cancer science throughout their career and are recognised for their outstanding contribution to translational medicine, which has led to successful application in the clinic.
- Have published research results in highly cited peer-reviewed journals
- Be an oncology professional, medical or clinical oncologist
- Be an ESMO member
- Have not previously received the ESMO Award for Translational Research (the previous Hamilton Fairley Award)
- Have not received any other Award from ESMO within the last five (5) years
- Not be a current or recent (last two years) member of either the ESMO Executive Board, ESMO Council or the ESMO Nomination Committee
Final selection is made by the Selection Committee: ESMO President, ESMO President-Elect, ESMO Past-President, Chair of the ESMO Nomination Committee.